For the Inventor, By the Inventor

Enter assignee name

Pfizer Italia S.r.l.

USPTO Granted Patents = 23

CIPO Patents = 15

EPO Patents = 7

Trademarks = 1

Forward Citations = 226

Loading Chart...

Loading Chart...

86 inventors (with patents filed for the assignee):

Daniele Fancelli (9 out of 37 patents)

Mario Varasi (8 out of 72 patents)

Matteo D'Anello (6 out of 14 patents)

4. Maria Gabriella Brasca (6 out of 49 patents)

5. Katia Martina (6 out of 7 patents)

6. Barbara Salom (5 out of 11 patents)

7. Frederick Arthur Brookfield (4 out of 64 patents)

8. William John Trigg (4 out of 10 patents)

9. Edward Andrew Boyd (4 out of 33 patents)

10. Valeria Pittala′ (4 out of 5 patents)

11. Patrizia Giordano (4 out of 5 patents)

12. Jonathan Anthony Larard (4 out of 4 patents)

13. Simona Bindi (3 out of 14 patents)

14. Anna Vulpetti (3 out of 20 patents)

15. Francesco Angelucci (3 out of 31 patents)

23 patents: Sort by Forward Citations

1. 9649380 - Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin (2017-05-16),

2. 8273765 - Bicyclo-pyrazoles and pharmaceutical compositions comprising them (2012-09-25),

3. 8198298 - Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors (2012-06-12),

4. 8106069 - Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them (2012-01-31),

5. 7888508 - Pyrrolo[2,3-B]pyridine derivatives active as kinase inhibitors (2011-02-15),

6. 7786048 - Condensed heterocyclic pyrazole derivatives as kinase inhibitors (2010-08-31),

7. 7728140 - Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them (2010-06-01),

8. 7632854 - Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them (2009-12-15),

9. 7582628 - Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them (2009-09-01),

10. 7541378 - Condensed heterocyclic pyrazole derivatives as kinase inhibitors (2009-06-02),

11. 7541354 - Bicyclo-pyrazoles (2009-06-02),

12. 7531531 - Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles (2009-05-12),

13. 7511136 - Aminoindazole derivatives active as kinase inhibitors (2009-03-31),

14. 7485661 - Heterobicyclic pyrazole derivatives as kinase inhibitors (2009-02-03),

15. 7462643 - Essential fatty acids in the prevention of cardiovascular events (2008-12-09),

Pfizer Italia S.R.L. is the Italian subsidiary of Pfizer, a leading global pharmaceutical company. Pfizer Italia operates in the Italian market, focusing on the research, development, and production of innovative healthcare solutions. With a strong commitment to patient health and well-being, Pfizer Italia aims to provide effective and safe pharmaceutical products for a wide range of medical conditions. Through collaborations and partnerships, Pfizer Italia drives advancements in healthcare by investing in cutting-edge research and technological innovation.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

23 Patents

#17 in

#404 in Italy

#26,790 in the World

Pfizer Italia S.r.l.

Forward Citations = 226

86 inventors:

Daniele Fancelli (9 out of 37 patents)

Mario Varasi (8 out of 72 patents)

Matteo D'Anello (6 out of 14 patents)

4. Maria Gabriella Brasca (6 out of 49 patents)

5. Katia Martina (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…